Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yingshuang Zhu"'
Autor:
Malcolm Dunlop, Jing Sun, Lijuan Wang, Xue Li, Mingyang Song, Harry Campbell, Evropi Theodoratou, Shuai Yuan, Igor Rudan, Yingshuang Zhu, Kefeng Ding, Jianhui Zhao, Susanna Larsson, Liying Xu, Zhengwei Wan, Konstantinos Tsilidis, Peige Song
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective This study aimed to explore the global burden of early-onset cancer based on the Global Burden of Disease (GBD) 2019 study for 29 cancers worldwid.Methods and analysis Incidence, deaths, disability-adjusted life years (DALYs) and risk facto
Externí odkaz:
https://doaj.org/article/3db25d475e1442ef8271c70d98d027b4
Autor:
Wei Lu, Dongliang Fu, Xiangxing Kong, Zhiheng Huang, Maxwell Hwang, Yingshuang Zhu, Liubo Chen, Kai Jiang, Xinlin Li, Yihua Wu, Jun Li, Ying Yuan, Kefeng Ding
Publikováno v:
Cancer Medicine, Vol 9, Iss 4, Pp 1419-1429 (2020)
Abstract Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differential
Externí odkaz:
https://doaj.org/article/53b752c9072243a3b189c9cb16dd51ed
Autor:
Yucheng Qian, Jingsun Wei, Wei Lu, Fangfang Sun, Maxwell Hwang, Kai Jiang, Dongliang Fu, Xinyi Zhou, Xiangxing Kong, Yingshuang Zhu, Qian Xiao, Yeting Hu, Kefeng Ding
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
PurposeWe focused on immune-related genes (IRGs) derived from transcriptomic studies, which had the potential to stratify patients’ prognosis and to establish a risk assessment model in colorectal cancer.SummaryThis article examined our understandi
Externí odkaz:
https://doaj.org/article/b289a6a8ac574db9b038cdcdb68fbba2
Publikováno v:
Holistic Integrative Oncology. 2
Purpose Intensive postoperative chemotherapy treatment use in early-onset colon cancer and late-onset colon cancer remains to be defined and their effects on prognosis were unclear. This study aims to investigate whether intensive adjuvant chemothera
Autor:
Lili Yu, Gang Zhao, Lijuan Wang, Xuan Zhou, Jing Sun, Xinxuan Li, Yingshuang Zhu, Yazhou He, Kleovoulos Kofonikolas, Debby Bogaert, Malcolm Dunlop, Yimin Zhu, Evropi Theodoratou, Xue Li
Publikováno v:
Yu, L, Zhao, G, Wang, L, Zhou, X, Sun, J, Li, X, Zhu, Y, He, Y, Kofonikolas, K, Bogaert, D, Dunlop, M, Zhu, Y, Theodoratou, E & Li, X 2022, ' A systematic review of microbial markers for risk prediction of colorectal neoplasia ', British Journal of Cancer, vol. 126, no. 9, pp. 1318-1328 . https://doi.org/10.1038/s41416-022-01740-7
Background Substantial evidence indicates that dysbiosis of the gut microbial community is associated with colorectal neoplasia. This review aims to systematically summarise the microbial markers associated with colorectal neoplasia and to assess the
Autor:
Qian Xiao, Yimin Fang, Qilong Li, Jinhuan Yang, Meilin Wang, Qi Dong, Mingjuan Jin, Xiangxing Kong, Yingshuang Zhu, Yunfeng Zhu, Yanqin Huang, Jinjie He, Kefeng Ding, Yeting Hu, Shu Zheng, Kun Chen
Publikováno v:
International Journal of Cancer. 150:594-602
Patients with conventional adenoma removal are recommended to undergo colonoscopy surveillance to prevent colorectal cancer (CRC). However, evidence supporting the guidelines of colonoscopy surveillance is limited, especially among the Chinese popula
Autor:
Jie Hu1,2,3, Hongzhi Zhao4, Braun, Joseph M.2, Tongzhang Zheng2, Bin Zhang5, Wei Xia1, Wenxin Zhang1, Jiufeng Li4, Yanqiu Zhou4, Han Li1, Jun Li1,6,7, Aifen Zhou5, Yiming Zhang5, Buka, Stephen L.2, Simin Liu2,8, Yang Peng1, Chuansha Wu1, Minmin Jiang1, Wenqian Huo1,9, Yingshuang Zhu1,10,11
Publikováno v:
Environmental Health Perspectives. Oct2019, Vol. 127 Issue 10, p107001-1-107001-11. 11p.
Autor:
Yingshuang Zhu, Yeting Hu, Xiangxing Kong, Qian Xiao, Zhizhong Pan, Zhaoxu Zheng, Ye Wei, Wang Ziqiang, Da Wang, Jiaqi Chen, Kun Chen, Shu Zheng, Meilin Wang, Xifeng Wu, Kefeng Ding
Publikováno v:
BMJ Open
PurposeThe National Colorectal Cancer Cohort (NCRCC) study aims to specifically assess risk factors and biomarkers related to endpoints across the colorectal cancer continuum from the aetiology through survivorship.ParticipantsThe NCRCC study include
Autor:
Liying Xu, Jianhui Zhao, Zihan Li, Jing Sun, Ying Lu, Rongqi Zhang, Yingshuang Zhu, Kefeng Ding, Rudan, Igor, Theodoratou, Evropi, Peige Song, Xue Li
Publikováno v:
Journal of Global Health; 2023, Vol. 13, p1-16, 16p
Autor:
Ying Yuan, Liubo Chen, Dongliang Fu, Jun Li, Yingshuang Zhu, Xinlin Li, Zhiheng Huang, Kefeng Ding, Yihua Wu, Wei Lu, Maxwell Hwang, Xiangxing Kong, Kai Jiang
Publikováno v:
Cancer Medicine, Vol 9, Iss 4, Pp 1419-1429 (2020)
Cancer Medicine
Cancer Medicine
Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differentially expres